Cross-platform prediction of gene expression signatures.
Gene expression signatures can predict the activation of oncogenic pathways and other phenotypes of interest via quantitative models that combine the expression levels of multiple genes. However, as the number of platforms to measure genome-wide gene expression proliferates, there is an increasing need to develop models that can be ported across diverse platforms. Because of the range of technologies that measure gene expression, the resulting signal values can vary greatly. To understand how this variation can affect the prediction of gene expression signatures, we have investigated the ability of gene expression signatures to predict pathway activation across Affymetrix and Illumina microarrays. We hybridized the same RNA samples to both platforms and compared the resultant gene expression readings, as well as the signature predictions. Using a new approach to map probes across platforms, we found that the genes in the signatures from the two platforms were highly similar, and that the predictions they generated were also strongly correlated. This demonstrates that our method can map probes from Affymetrix and Illumina microarrays, and that this mapping can be used to predict gene expression signatures across platforms.
Graduate School of Biomedical Sciences, University of Texas, Houston, Texas, United States of America.
Shu-Hong
SH
Lin
Lauren
L
Beane
Dawn
D
Chasse
Kevin W
KW
Zhu
Bernard
B
Mathey-Prevot
Jeffrey T
JT
Chang
D045744:Cell Line, Tumor; D020869:Gene Expression Profiling / Q000295:instrumentation* / Q000379:methods*; D005786:Gene Expression Regulation; D055106:Genome-Wide Association Study; D006801:Humans; D020411:Oligonucleotide Array Sequence Analysis / Q000295:instrumentation* / Q000379:methods*